The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
Roche says the move marks a step forward in its digital transformation strategy
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Surgical site infections and antimicrobial resistance remain major challenges globally
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Subscribe To Our Newsletter & Stay Updated
